| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 4, Issue 6 495-501, Copyright © 1993 by American Association of Cancer Research
ARTICLES |
JA Barnard and G Warwick
Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-2576.
Selected G1 events associated with butyrate-induced differentiation were examined in HT-29 colon adenocarcinoma cells. [3H]Thymidine incorporation by HT-29 cells was decreased to 40% of control levels by treatment with 5 mM butyrate for 24 h, and cell numbers decreased to 21% of control levels after 48 h of treatment. Cells released from butyrate arrest entered S phase approximately 24 h after release, and serum-deprived HT-29 cells escaped growth inhibition if butyrate was added 8 h or more after serum restimulation. Northern analysis of RNA isolated from rapidly growing HT-29 cells showed a marked induction of alkaline phosphatase mRNA expression within 12 h of treatment with 5 mM butyrate. The appearance of alkaline phosphatase mRNA was temporally associated with a 5-fold increase in expression of transforming growth factor beta 1 (TGF-beta 1) mRNA. Expression of the nuclear protooncogene c-myc began to decrease 30 min after treatment with butyrate and was decreased 4.5-fold 4 h after treatment; however, expression of other immediate-early genes (nup/475 and zif/268) was not significantly affected. Histochemical staining of HT-29 monolayers showed that no cells were positive for alkaline phosphatase protein prior to treatment, and 90% were positive 48 h after treatment. TGF-beta 1 and TGF-beta 2 had no effect on HT-29 cell growth. TGF-beta 1 did not induce alkaline phosphatase mRNA or histochemical positivity. These data indicate that butyrate arrests HT-29 cell growth early in G1.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
![]() |
H. T. Tan, S. Tan, Q. Lin, T. K. Lim, C. L. Hew, and M. C. M. Chung Quantitative and Temporal Proteome Analysis of Butyrate-treated Colorectal Cancer Cells Mol. Cell. Proteomics, June 1, 2008; 7(6): 1174 - 1185. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ishihama, M. Yamakawa, S. Semba, H. Takeda, S. Kawata, S. Kimura, and W. Kimura Expression of HDAC1 and CBP/p300 in human colorectal carcinomas J. Clin. Pathol., November 1, 2007; 60(11): 1205 - 1210. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. W. Lee, J. H. Suh, A Y. Kim, Y. S. Lee, S. Y. Park, and J. B. Kim Histone Deacetylase 1-Mediated Histone Modification Regulates Osteoblast Differentiation Mol. Endocrinol., October 1, 2006; 20(10): 2432 - 2443. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Bartova, J. Pachernik, A. Harnicarova, A. Kovarik, M. Kovarikova, J. Hofmanova, M. Skalnikova, M. Kozubek, and S. Kozubek Nuclear levels and patterns of histone H3 modification and HP1 proteins after inhibition of histone deacetylases J. Cell Sci., November 1, 2005; 118(21): 5035 - 5046. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Y. Archer, J. Johnson, H.-J. Kim, Q. Ma, H. Mou, V. Daesety, S. Meng, and R. A. Hodin The histone deacetylase inhibitor butyrate downregulates cyclin B1 gene expression via a p21/WAF-1-dependent mechanism in human colon cancer cells Am J Physiol Gastrointest Liver Physiol, October 1, 2005; 289(4): G696 - G703. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Tong, L. Yin, S. Joshi, D. W. Rosenberg, and C. Giardina Cyclooxygenase-2 Regulation in Colon Cancer Cells: MODULATION OF RNA POLYMERASE II ELONGATION BY HISTONE DEACETYLASE INHIBITORS J. Biol. Chem., April 22, 2005; 280(16): 15503 - 15509. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bordin, F. D'Atri, L. Guillemot, and S. Citi Histone Deacetylase Inhibitors Up-Regulate the Expression of Tight Junction Proteins Mol. Cancer Res., December 1, 2004; 2(12): 692 - 701. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yuan, F. J. Liddle, S. Mahajan, and D. A. Frank IL-6-induced survival of colorectal carcinoma cells is inhibited by butyrate through down-regulation of the IL-6 receptor Carcinogenesis, November 1, 2004; 25(11): 2247 - 2255. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kurita-Ochiai, S. Seto, and K. Ochiai Role of Cell-Cell Communication in Inhibiting Butyric Acid-Induced T-Cell Apoptosis Infect. Immun., October 1, 2004; 72(10): 5947 - 5954. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Y. Chen, S. Rex, and C.-C. Tseng Kruppel-Like Factor 4 Is Transactivated by Butyrate in Colon Cancer Cells J. Nutr., April 1, 2004; 134(4): 792 - 798. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Karp, H. Pan, M. Zhang, D. J. Buckley, L. A. Schuler, and A. R. Buckley Identification of HRPAP20: A Novel Phosphoprotein that Enhances Growth and Survival in Hormone-Responsive Tumor Cells Cancer Res., February 1, 2004; 64(3): 1016 - 1025. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kurita-Ochiai, S. Amano, K. Fukushima, and K. Ochiai Cellular Events Involved in Butyric Acid-Induced T Cell Apoptosis J. Immunol., October 1, 2003; 171(7): 3576 - 3584. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Merchant, L. Bai, and M. Okada ZBP-89 Mediates Butyrate Regulation of Gene Expression J. Nutr., July 1, 2003; 133(7): 2456S - 2460. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sonoyama, P. Pholnukulkit, M. Toyoda, S. Rutatip, and T. Kasai Upregulation of activin A gene by butyrate in human colon cancer cell lines Am J Physiol Gastrointest Liver Physiol, June 1, 2003; 284(6): G989 - G995. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. F. Hinnebusch, S. Meng, J. T. Wu, S. Y. Archer, and R. A. Hodin The Effects of Short-Chain Fatty Acids on Human Colon Cancer Cell Phenotype Are Associated with Histone Hyperacetylation J. Nutr., May 1, 2002; 132(5): 1012 - 1017. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Domon-Dell, Q Wang, S Kim, M Kedinger, B M Evers, and J-N Freund Stimulation of the intestinal Cdx2 homeobox gene by butyrate in colon cancer cells Gut, April 1, 2002; 50(4): 525 - 529. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. X. Cao, I. Mohuiddin, F. Ece, D. J. McConkey, and W. R. Smythe Histone Deacetylase Inhibitor Downregulation of bcl-xl Gene Expression Leads to Apoptotic Cell Death in Mesothelioma Am. J. Respir. Cell Mol. Biol., November 1, 2001; 25(5): 562 - 568. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Walker, E. M. Wilson, D. Powell, and Y. Oh Butyrate, a Histone Deacetylase Inhibitor, Activates the Human IGF Binding Protein-3 Promoter in Breast Cancer Cells: Molecular Mechanism Involves an Sp1/Sp3 Multiprotein Complex Endocrinology, September 1, 2001; 142(9): 3817 - 3827. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Topping and P. M. Clifton Short-Chain Fatty Acids and Human Colonic Function: Roles of Resistant Starch and Nonstarch Polysaccharides Physiol Rev, July 1, 2001; 81(3): 1031 - 1064. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Wu, S. Y. Archer, B. Hinnebusch, S. Meng, and R. A. Hodin Transient vs. prolonged histone hyperacetylation: effects on colon cancer cell growth, differentiation, and apoptosis Am J Physiol Gastrointest Liver Physiol, March 1, 2001; 280(3): G482 - G490. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fujita, Y. Furukawa, Y. Nagasawa, M. Ogawa, and Y. Nakamura Down-Regulation of Monocyte Chemotactic Protein-3 by Activated {beta}-Catenin Cancer Res., December 1, 2000; 60(23): 6683 - 6687. [Abstract] [Full Text] |
||||
![]() |
S. L. F. Pender, J. J. Quinn, I. R. Sanderson, and T. T. MacDonald Butyrate upregulates stromelysin-1 production by intestinal mesenchymal cells Am J Physiol Gastrointest Liver Physiol, November 1, 2000; 279(5): G918 - G924. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Sadar and M. E. Gleave Ligand-independent Activation of the Androgen Receptor by the Differentiation Agent Butyrate in Human Prostate Cancer Cells Cancer Res., October 1, 2000; 60(20): 5825 - 5831. [Abstract] [Full Text] |
||||
![]() |
Q. M. Wang, R. Feinman, F. Kashanchi, J. M. Houghton, G. P. Studzinski, and L. E. Harrison Changes in E2F Binding after Phenylbutyrate-induced Differentiation of Caco-2 Colon Cancer Cells Clin. Cancer Res., July 1, 2000; 6(7): 2951 - 2958. [Abstract] [Full Text] |
||||
![]() |
L. E. Harrison, Q. M. Wang, and G. P. Studzinski Butyrate-Induced G2/M Block in Caco-2 Colon Cancer Cells is Associated with Decreased p34cdc2 Activity Experimental Biology and Medicine, November 1, 1999; 222(2): 150 - 156. [Abstract] [Full Text] |
||||
![]() |
M. Giuliano, M. Lauricella, G. Calvaruso, M. Carabillo, S. Emanuele, R. Vento, and G. Tesoriere The Apoptotic Effects and Synergistic Interaction of Sodium Butyrate and MG132 in Human Retinoblastoma Y79 Cells Cancer Res., November 1, 1999; 59(21): 5586 - 5595. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bordonaro, J. M. Mariadason, F. Aslam, B. G. Heerdt, and L. H. Augenlicht Butyrate-induced Apoptotic Cascade in Colonic Carcinoma Cells: Modulation of the {beta}-Catenin-Tcf Pathway and Concordance with Effects of Sulindac and Trichostatin A but not Curcumin Cell Growth Differ., October 1, 1999; 10(10): 713 - 720. [Abstract] [Full Text] |
||||
![]() |
S. Ruller, C. Stahl, G. Kohler, B. Eickhoff, J. Breder, M. Schlaak, and J. van der Bosch Sensitization of Tumor Cells to Ribotoxic Stress-induced Apoptotic Cell Death: A New Therapeutic Strategy Clin. Cancer Res., October 1, 1999; 5(10): 2714 - 2725. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Glinghammar, K. Holmberg, and J. Rafter Effects of colonic lumenal components on AP-1-dependent gene transcription in cultured human colon carcinoma cells Carcinogenesis, June 1, 1999; 20(6): 969 - 976. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Rickard, P. R. Gibson, G. P. Young, and W. A. Phillips Activation of protein kinase C augments butyrate-induced differentiation and turnover in human colonic epithelial cells in vitro Carcinogenesis, June 1, 1999; 20(6): 977 - 984. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Kim, S. Meng, A. Shei, and R. A. Hodin A novel Sp1-related cis element involved in intestinal alkaline phosphatase gene transcription Am J Physiol Gastrointest Liver Physiol, April 1, 1999; 276(4): G800 - G807. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhang, G. Wu, R. S. Chapkin, and J. R. Lupton Energy Metabolism of Rat Colonocytes Changes during the Tumorigenic Process and Is Dependent on Diet and Carcinogen J. Nutr., August 1, 1998; 128(8): 1262 - 1269. [Abstract] [Full Text] |
||||
![]() |
C. P. Tran, M. Familari, L. M. Parker, R. H. Whitehead, and A. S. Giraud Short-chain fatty acids inhibit intestinal trefoil factor gene expression in colon cancer cells Am J Physiol Gastrointest Liver Physiol, July 1, 1998; 275(1): G85 - G94. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Y. Archer, S. Meng, A. Shei, and R. A. Hodin p21WAF1 is required for butyrate-mediated growth inhibition of human colon cancer cells PNAS, June 9, 1998; 95(12): 6791 - 6796. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Gao, T. Sedgwick, Y.-B. Shi, and T. Evans Distinct Functions Are Implicated for the GATA-4, -5, and -6 Transcription Factors in the Regulation of Intestine Epithelial Cell Differentiation Mol. Cell. Biol., May 1, 1998; 18(5): 2901 - 2911. [Abstract] [Full Text] |
||||
![]() |
J. A. Hochman, D. Sciaky, T. L. Whitaker, J. A. Hawkins, and M. B. Cohen Hepatocyte nuclear factor-1alpha regulates transcription of the guanylin gene Am J Physiol Gastrointest Liver Physiol, October 1, 1997; 273(4): G833 - G841. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nakano, T. Mizuno, Y. Sowa, T. Orita, T. Yoshino, Y. Okuyama, T. Fujita, N. Ohtani-Fujita, Y. Matsukawa, T. Tokino, et al. Butyrate Activates the WAF1/Cip1 Gene Promoter through Sp1 Sites in a p53-negative Human Colon Cancer Cell Line J. Biol. Chem., August 29, 1997; 272(35): 22199 - 22206. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Fitzgerald, M. Omary, and G Triadafilopoulos Acid modulation of HT29 cell growth and differentiation. An in vitro model for Barrett's esophagus J. Cell Sci., January 3, 1997; 110(5): 663 - 671. [Abstract] [PDF] |
||||
![]() |
L. Bai and J. L. Merchant Transcription Factor ZBP-89 Cooperates with Histone Acetyltransferase p300 during Butyrate Activation of p21waf1 Transcription in Human Cells J. Biol. Chem., September 22, 2000; 275(39): 30725 - 30733. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |